Effects of 5,5-diphenylhydantoin and related carbamates and hydroxylamines on nucleic acid and protein synthesis of proliferating human lymphocytes.
D015073:2-Acetylaminofluorene / Q000494:pharmacology; D000099:Acetoxyacetylaminofluorene / Q000494:pharmacology; D001798:Blood Proteins / Q000096:biosynthesis*; D002219:Carbamates / Q000494:pharmacology*; D004247:DNA / Q000096:biosynthesis*; D006801:Humans; D006827:Hydantoins / Q000494:pharmacology; D006881:Hydroxyacetylaminofluorene / Q000494:pharmacology; D006898:Hydroxylamines / Q000494:pharmacology*; D066298:In Vitro Techniques; D007930:Leucine / Q000097:blood; D008214:Lymphocytes / Q000378:metabolism*; D010672:Phenytoin / Q000031:analogs & derivatives / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013936:Thymidine / Q000097:blood
D001798:Blood Proteins; D002219:Carbamates; D006827:Hydantoins; D006898:Hydroxylamines; D006881:Hydroxyacetylaminofluorene; D000099:Acetoxyacetylaminofluorene; D010672:Phenytoin; D004247:DNA; D015073:2-Acetylaminofluorene; D007930:Leucine; D013936:Thymidine